<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01344330</url>
  </required_header>
  <id_info>
    <org_study_id>P01CA090890</org_study_id>
    <secondary_id>P01CA090890</secondary_id>
    <nct_id>NCT01344330</nct_id>
  </id_info>
  <brief_title>Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients</brief_title>
  <official_title>Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas A&amp;M University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas A&amp;M University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study will assess cruciferous vegetable intake in patients presenting for
      screening colonoscopy and correlate intake with histone status and histone deacetylace (HDAC)
      expression in tissue biopsy specimens and peripheral blood mononuclear cells (PBMCs). The
      investigators will also measure sulforaphane (SFN) metabolites in blood as a biomarker of
      cruciferous vegetable intake.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cruciferous vegetable intake correlated with SFN and I3C urinary metabolites</measure>
    <time_frame>At colonoscopy (day 1)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cruciferous vegetable intake and p21 expression (qRT-PCR, ChIP in PBMCs)</measure>
    <time_frame>at colonoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cruciferous vegetable intake correlated with acetylated histone expression (PBMCs, colon tissue),</measure>
    <time_frame>at colonoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cruciferous vegetable intake correlated with HDAC activity (in PBMCs)</measure>
    <time_frame>at colonoscopy</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Screening colonoscopy patients</arm_group_label>
    <description>Men and women age 50 to 75 scheduled for screening colonoscopy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for screening colonoscopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  scheduled for screening colonoscopy

          -  off NSAID or aspirin therapy in accordance with OHSU endoscopy clinic guidelines

          -  INR 0.90-1.20

          -  hemoglobin ≥ 13.5 (men) or 12.0 (women)

          -  platelets ≥100,000/μL

          -  Chem screen results within normal limits

          -  negative (serum or urine) pregnancy test done ≤7 days prior to colonoscopy for women
             of childbearing potential only

          -  ASA performance status &lt;2

        Exclusion criteria:

          -  history of colon cancer or adenomatous polyps

          -  current smoker

          -  medical history of chronic obstructive pulmonary disease

          -  current oral steroid therapy

          -  current therapy with valproate or other pharmacological drugs associated with HDAC
             inhibition

          -  use of oral antibiotics within 3 months prior to entry into study

          -  significant active medical illness which in the opinion of the investigator would
             preclude collection/interpretation of colon tissue

          -  diagnosis of hemophilia, van Willebrand's disease or other bleeding disorder

          -  use of warfarin or other blood thinning agents

          -  inflammatory bowel disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rod Dashwood, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>To be named</last_name>
  </overall_contact>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew French</last_name>
      <phone>503-494-7004</phone>
      <email>frenchm@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Carrie Farrar</last_name>
      <phone>503-494-4233</phone>
      <email>farrarc@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Lieberman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2011</study_first_submitted>
  <study_first_submitted_qc>April 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2011</study_first_posted>
  <last_update_submitted>May 6, 2016</last_update_submitted>
  <last_update_submitted_qc>May 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colon cancer</keyword>
  <keyword>Prevention</keyword>
  <keyword>Cruciferous vegetables</keyword>
  <keyword>Histone status</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Group information (High versus Low Cruciferous Vegetable Intake) will be made available. No IPD will be made available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

